Announcements Trials
Browse Landscape

Phase

Phase NA 3

Status

Recruiting 5Active not recruiting 3Not yet recruiting 2Terminated 1Completed 1

Sponsor Class

OTHER 47NETWORK 3

Study Type

Interventional 3

Sponsor

Cancer Type

Tumor-Agnostic 1Genitourinary 1Breast 1

Conditions

Renal Insufficiency, Chronic 1Neoplasm Metastasis 1Cardiovascular Diseases 1Carcinoma, Renal Cell 1Carcinoma, Medullary 1Anatomic Stage I Breast Cancer AJCC v8 1

Interventions

Specimen Handling 19Cyclophosphamide 18Magnetic Resonance Spectroscopy 17Vincristine 16Dexamethasone 15Radiotherapy 14Cisplatin 14Radiation 12Etoposide 11Doxorubicin 11Radiotherapy, Intensity-Modulated 10Carboplatin 10durvalumab 9Paclitaxel 9Cytarabine 8Temozolomide 7Rituximab 7Radiotherapy, Conformal 7Prednisone 7Lenalidomide 7Irinotecan 7Gemcitabine 7Fluorouracil 7Docetaxel 7Bortezomib 7Biopsy 7daratumumab 6Platinum 6Leucovorin 6Capecitabine 6

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Active not recruiting × NETWORK × Practice Guidelines as Topic × Clear all
NCT04467021 2026-05-06

Cancer and Blood Pressure Management, CARISMA Study

Eastern Cooperative Oncology Group

Phase NA Active not recruiting
61 enrolled
Genitourinary

Carcinoma, Renal Cell, Cardiovascular Diseases, Carcinoma, Medullary, Renal Insufficiency, Chronic

NCT05568472 2026-04-02

ASPEN

SWOG Cancer Research Network

Phase NA Active not recruiting
565 enrolled
Breast

Anatomic Stage I Breast Cancer AJCC v8

NCT05455606 2026-01-22

Does the Use of a Genomic Tumor Board Increase the Number of Patients Who Receive Genome-Informed Treatment

SWOG Cancer Research Network

Phase NA Active not recruiting
1,284 enrolled
Tumor-Agnostic

Neoplasm Metastasis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡